PR Newswire - Financial

NEURALSTEM, Inc. Add to My Watchlist

(AMEX: CUR)

Detailed Quote

News

Last Price	1.80 (11.20.09 6:40 PM EST)
Change (%)	+0.12 (+7.14%)
Volume	120,847
Open	1.60
Previous Close	1.68
Day High	1.84
Day Low	1.57
Bid	1.55 x 1000
Ask	1.84 x 100

Average Volume	277,395
Shares Outstanding	34.83M
Market Cap	62.7M
Year High	2.95
Year Low	0.75
Earnings Per Share	-0.32
P/E Ratio	-
Dividend	N/A
Yield	N/A

Intraday

3 Month

6 Month

1 Year

Symbol	Last	Change (%)
IMYNE	0.28	+0.02 (+7.69%)
AMSJF	0.48	+0.00 (+0.00)
BOLT	1.16	+0.00 (+0.00)
PURE	1.96	-0.03 (-1.51%)
MDG	0.73	-0.01 (-1.35%)
LVCLY	2.80	+0.02 (+0.72%)
PLI	0.23	+0.02 (+12.50%)

Tue, Nov 17, 2009
	Neuralstem, Inc. Reports Third Quarter Financial Results and Provides Business Update - PR Newswire
Mon, Oct 05, 2009
	/R E P E A T -- DiagnoCure signs distribution agreement in the UK for its colorectal cancer test/ - PR Newswire
	DiagnoCure signs distribution agreement in the UK for its colorectal cancer test - PR Newswire
Mon, Sep 21, 2009
	Neuralstem Receives FDA Approval to Commence First ALS Stem Cell Trial - PR Newswire
Mon, Sep 14, 2009
	Diagnocure announces third quarter 2009 financial results - PR Newswire
More Featured Content

Mon, Sep 21, 2009
	Unusual 11 Mid-Day Movers 9/21: CHIP, PER, HNSN, CUR Higher; DPTR, BUSE, IBNK, RPRX Lower Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4958696 for the full story. - StreetInsider
	Today's Morning Top Gainers (HNSN,FFBC,CUR,PER,CHIP) VeriChip Corporation (NASDAQ: CHIP) is among the top percentage gainers in morning trade and surged 225% to $3.73 on huge volume of 12.78 million shares after VeriChip and its development partner RECEPTORS LLC, announced today that VeriChip has been granted an exclusive license to RECEPTORS' Patent No. 7,504,364 titled “Methods of Making Arrays and Artificial Receptors” and Patent No. 7,469,076 “Sensors Employing Combinatorial Artificial Receptors,” in their application to the development of the virus triage detection system for the H1N1 virus. - Benzinga
	Morning Movers 9/21: CHIP, PER, CUR, LUNA, AEZS, NKTR Higher; DPTR, RPRX, PEIX, ATGN, QCOR, HPOL Lower Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4958179 for the full story. - StreetInsider
	Neuralstem (CUR) Surges on FDA Approval To Start First ALS Stem Cell Trial Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4957540 for the full story. - StreetInsider
	Neuralstem (CUR) Receives FDA Approval to Commence First ALS Stem Cell Trial Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4957392 for the full story. - StreetInsider
More News

Mon, Sep 21, 2009
	BioMed News Bytes: CUR, IPXL, QCOR, VRX On 9/21/09, Neuralstem (AMEX: CUR) ($2.50, +34%, heavy volume) announced that the FDA has approved its Investigational New Drug (IND) application to commence a Phase I trial to treat Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig’s disease) with its spinal cord stem cells.[More...] - home: iStockAnalyst....
More Blogs

02/09/09		Special Conference Neuralstem, Inc. at Biotechnology Industry Organization BIO CEO and Investor Conference Archive for CUR
10/06/08		Special Conference DiagnoCure to present at the JMP Securities Healthcare Focus Conference Archive for CUR
11/05/07		Special Conference Acumen Biofin Rodman & Renshaw 9th Annual Healthcare Conference Archive for CUR

Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Investing News provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs